Results 41 to 50 of about 103,807 (98)

Targeting MCL-1 and MAPK overcomes venetoclax resistance in FLT3-ITD-positive AML cells harbouring activating PTPN11 (SHP-2) mutations. [PDF]

open access: yesBr J Haematol
Fleischmann M   +12 more
europepmc   +1 more source

Precision Medicine in Treating Lung Cancer: A Narrative Review on Treatments Targeting Oncogenic Genetic Mutations. [PDF]

open access: yesCureus
Chitneni E   +9 more
europepmc   +1 more source

A hotspot phosphorylation site on SHP2 drives oncoprotein activation and drug resistance. [PDF]

open access: yesNat Commun
Karunaraj P   +13 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy